XNAS · Healthcare · Medical Devices
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | Q1 2026 | -0.16 | -0.19 | -18.75% | $30.9M | ❌ Miss | -3.39% | -18.14% | — |
| 2026-02-25 | Q4 2025 | -0.28 | -0.03 | +89.29% | $32.6M | ✅ Beat | -9.08% | -9.99% | -28.94% |
| 2025-11-05 |
| Q3 2025 |
| -0.27 |
| -0.04 |
| +85.19% |
| $30.3M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-07 | Q2 2025 | -0.18 | -0.08 | +55.56% | $33.6M | ✅ Beat | -2.44% | +5.52% | +14.12% |
| 2025-02-25 | Q4 2024 | -0.01 | 0.03 | +400.00% | $40.2M | ✅ Beat | -0.82% | -8.05% | -8.70% |
| 2024-11-07 | Q3 2024 | -0.25 | 0.00 | +100.00% | $35.3M | ✅ Beat | -5.59% | -13.16% | -21.97% |
| 2023-11-09 | Q3 2023 | -0.43 | -0.19 | +55.81% | $22.2M | ✅ Beat | +6.22% | +18.19% | +47.23% |
| 2023-08-07 | Q2 2023 | -0.47 | -0.28 | +40.43% | $20.8M | ✅ Beat | +2.74% | +2.50% | +2.36% |
Showing last 8 quarters.